Algorae wins NSW Health public hospital contract
Algorae Pharmaceuticals (ASX:1AI) has secured a three-year public hospital supply contract with NSW Health.
Algorae Pharmaceuticals (ASX:1AI) has secured a three-year public hospital supply contract with NSW Health.
Anthropic will restore public access to its Claude Fable 5 and Mythos 5 artificial intelligence models after the US government lifted export controls that had restricted access since June 12 following security concerns.
New York Life Investment Management (NYLIM) has partnered with Centrifuge to launch its first tokenised investment product, giving eligible investors onchain access to the firm's US high-yield corporate bond strategy through the HYB fund.
Enlitic (ASX:ENL) signed a three-year Ensight subscription contract worth $359,000 with Lumus Imaging to enter the Australian market.
Nigeria's cryptocurrency market is moving towards stricter oversight as the Securities and Exchange Commission and the Central Bank of Nigeria expand licensing, know-your-customer and anti-money laundering requirements for digital asset platforms.
Global commerce company RooLife Group (ASX:RLG) announced four major leadership changes effective from July 1.
A total of 71 cryptocurrency hacking incidents were recorded globally during the second quarter of 2026, the highest quarterly figure since 2020.
US-listed spot Bitcoin (CRYPTO:BTC) exchange-traded funds recorded net outflows of US$4.5 billion in June 2026.
Belden (NYSE:BDC) announced that it has completed its acquisition of RUCKUS Networks, a global provider of intelligent network solutions, from Vistance Networks (NASDAQ:VISN).
DraftKings has launched its DKeX prediction market exchange, moving its DraftKings Predictions platform onto infrastructure it owns after previously routing trades through CME Group and Crypto.com.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy